Purpose: Migration of endovascular stent grafts has been related to the security of proximal device fixation to the aortic neck. This study evaluated the importance of iliac fixation in preventing longitudinal in vivo device displacement of a modular, externally supported stent graft. Methods: Experimental ovine infrarenal aneurysms (n ‫؍‬ 8) were treated with a fully supported, modular, bifurcated stent graft (AneuRx, Medtronic, Santa Rosa, Calif). Minimum iliac fixation length (1 cm) was used in four animals and iliac extender modules were used to achieve maximum iliac fixation in four animals. Suture anastomosis of bifurcated polyester grafts to the infrarenal aorta served as controls (n ‫؍‬ 8). Aortic grafts were displaced in vivo by applying downward traction to a guidewire that was passed over the iliac flow divider and brought out both femoral arteries. The displacement force needed to initiate stent-graft migration was recorded and compared with the force needed to disrupt the sutured anastomosis. 
Endovascular aneurysm repair has gained acceptance in the treatment of abdominal aortic aneurysms with favorable results compared with open surgery . [1] [2] [3] Large, prospective, clinical trials have reported freedom from aneurysm-related death in 97% of patients and freedom from surgical conversion in 90% of patients after 4 years. 4 However, the longterm results of endovascular aneurysm repair may be compromised by late adverse events such as endograft migration, aneurysm enlargement, stent fracture, and endoleaks.
Migration has been reported with all endovascular devices, with an incidence of 2% at 1 year in each of the clinical trials of United States Food and Drug Administration (FDA)-approved devices. [5] [6] [7] The cause of migration is most often associated with abnormalities of the proximal aortic neck and problems with fixation and seal of the proximal end of the endograft to the aortic neck.
Increasing neck angulation and neck diameter, Ͼ30% proximal graft oversizing, short proximal aortic neck length, and low initial device deployment in relation to the renal arteries have all been shown to increase the risk of migration. [8] [9] [10] [11] [12] [13] [14] However, the importance of distal fixation to the iliac arteries in relation to stent graft migration has received little attention.
The purpose of this study was to determine whether iliac fixation length is an important factor in resisting in vivo device displacement of a bifurcated endograft with longitudinal columnar support. An experimental model was used to compare a modular, externally supported stent graft (AneuRx, Medtronic, Santa Rosa, Calif) with standard prosthetic aortic grafts that has a sutured anastomosis to the aorta.
METHODS
An ovine model of surgically constructed abdominal aortic aneurysms was used. The sheep were premedicated with intravenous (IV) ketamine (10 mg/kg ) and Valium (0.5mg/kg IV) (Roche Laboratories) or intramuscular (IM) Telazol (6-8mg/kg IM). Atropine (0.04mg/kg IM) was given to decrease respiratory secretions and prevent bradycardia. Upon induction of light anesthesia, the subject animal was intubated. Isoflurane (1.0% to 5.0% to effect by inhalation) in oxygen was administered to maintain a surgical plane of anesthesia. The heart rate, rhythm, blood pressure, hemoglobin oxygen saturation, and respiratory rate were monitored throughout the procedure.
A midline laparotomy was performed after adequate general endotracheal anesthesia was obtained and appropriate monitoring catheters were placed. The proximal aorta and common iliac arteries were dissected and controlled. The animal was heparinized with 100 U/kg of heparin and the activated clotting time was maintained Ͼ250 seconds throughout the procedure.
The infrarenal aorta and iliac arteries were clamped and the anterior wall of the aorta was opened, beginning 2.5 cm below the lowermost renal artery. A large, polyester Hemashield fabric patch (Boston Scientific, Natick, Mass) was sutured to the anterior aortotomy, creating an aneurysmal dilatation of infrarenal aorta that was twice the normal diameter of the aorta (Fig 1) .
The infrarenal neck of each experimental aneurysm was 20 mm long. The inferior junction of lowermost renal artery was marked with surgical clips that served as the reference marker for subsequent fluoroscopic determination of stent-graft movement and displacement. The midline laparotomy was then closed with a running 2-0 Prolene (Ethicon, Somerville, NJ) suture.
Bilateral groin incisions were made for exposure of the common femoral arteries. Using the Seldinger technique, the femoral arteries were accessed with bilateral 7F sheaths. A marker pigtail catheter was placed at the level of the renal arteries, and an angiogram was obtained to measure the length from the renal arteries to the aortic trifurcation. The aortic neck and common iliac artery diameters were measured manually with calipers applied to the outer wall of the vessel after dissection. Computed tomography (CT) angiographic measurements were not performed. Aortic anatomy is given in Table 1 . These anatomic criteria were used to choose the smallest diameter endograft (20 ϫ 12 mm) for both groups.
Two stiff 0.035 guidewires were positioned and a 20 ϫ 12 mm bifurcation stent-graft module (AneuRx) was advanced to the level of the renal arteries and deployed under fluoroscopic guidance. The bifurcation module was rotated and positioned in a cross-limbed fashion. This was done to shorten the effective length of the stent graft, because the shortest graft available was 13.5 cm and the distance from the renal arteries to the trifurcation was 11 cm. By crossing the iliac limbs, the effective length of the device was decreased by 1.5 cm, which resulted in an iliac fixation length of about 1 cm. This configuration was maintained in both groups of animals so as not to be a confounding variable.
After the bifurcation module was deployed, the gate was cannulated and the contralateral iliac limb was deployed with a similar 1-cm iliac fixation length. Standard bifurcation device deployment with short iliac fixation (1 cm) was used in four animals. In four animals, iliac extender modules were deployed bilaterally to cover the entire length of the common iliac arteries. This resulted in a 3-cm iliac fixation length bilaterally (maximum iliac fixation group).
After stent graft placement, a 0.035 glidewire was snared above the flow divider and brought out through the contralateral femoral artery (Fig 2) . A catheter was advanced over the wire to protect the top edge of the bifurcation module flow divider. Both ends of the wire were connected to a Chatillon TurboGauge at the foot of the animal. Under fluoroscopic control, continuous longitudinal downward traction was applied to each aortic endograft by pulling on both ends of the guidewire (Fig  3) . Movement of the stent graft in relation to the markers on the lowermost renal artery was recorded by cine fluoroscopy. The peak force at the time of initial stent graft displacement was recorded by the TurboGauge and was measured in newtons. Migration was defined as an increase in distance from the lowermost renal artery to the top of the stent graft.
After the pull-down force measurements were completed, the abdominal cavity was reopened. The aorta and iliac arteries were cross-clamped, the experimental aneurysm was opened, and the stent graft was removed. The suprarenal aorta was transected and a bifurcated 14 ϫ 7 mm knitted Dacron (DuPont) surgical graft was sutured endto-end to normal aorta that had not been previously manipulated The anastomosis was performed with a running 4-0 Prolene suture.
After the anastomosis was completed, a glidewire was passed over the flow divider of the surgical graft and brought out both limbs of the graft. A catheter was passed over the glidewire to protect the flow divider of the Dacron (DuPont) graft. Both ends of the glidewire were connected to the Chatillon TurboGauge in the same manner as had been previously used to apply downward traction force to the stent graft. Clamps were applied to the iliac limbs and the proximal aortic clamp was removed. Downward traction force was applied to the aortic graft, with video image observation and recording of the aortic anastomosis.
The peak force recorded on the Chatillon Turbogauge at the time the anastomosis began to tear was measured and recorded in newtons. The aorta was then immediately cross-clamped and the sheep was euthanized. All device implant and explant procedures were performed in accordance with the Principles of Laboratory Animal Care and the Animal Welfare Act (1970 and amendments) and approved by the animal care committee.
Results are reported as the mean Ϯ standard deviation. Differences between two groups were performed using the Student t test. Differences among the three groups were analyzed using analysis of variance. A P Ͻ .05 was considered statistically significant.
RESULTS
There was no difference in animal size (88.8 Ϯ 2.5 kg vs 87.5 Ϯ 2.9 kg), aortic neck diameter (12.7 Ϯ 0.9 mm vs 13.4 Ϯ 1.1 mm), aortic neck length (23.2 Ϯ 0.9 mm vs 21.8 Ϯ 2.4 mm), aneurysm size (24.7 Ϯ 1.1 mm vs 24.2 Ϯ 2.0 mm), or iliac artery diameter (9.0 Ϯ 1.5 mm vs 9.3 Ϯ 0.5 mm) between the groups with minimum and maximum iliac fixation. Complete aorta morphology is given in Table 1 .
The smallest diameter aortic endograft was chosen for all eight sheep experiments. The device was a 20 x 12 mm AneuRx aortic graft. This resulted in 50% oversizing of the graft in the proximal neck for the minimum iliac fixation group, a 57% oversizing in the maximum iliac fixation group (P ϭ NS), and a 30% oversizing of the iliac vessels in both groups. The length of the bifurcation module was 13.5 cm in all animals.
In animals with minimum iliac fixation, no extender cuffs were placed. In animals with maximal iliac fixation, one 5.5-cm extender cuff was placed on each side with a 2.5-cm overlap between the iliac limb and the extender cuff. Iliac fixation length was 31.0 Ϯ 0.3 mm in maximum fixation animals and 11 Ϯ 0.25 mm in minimum fixation animals (P Ͻ .0001).
The peak force to initiate migration was 30.2 Ϯ 5.5 N (range, 25 to 38) in animals with maximum iliac fixation compared with 18.1 Ϯ 3.7 N (range, 13 to 21) in those with minimum iliac fixation (P ϭ .01) ( Table II) . The peak force to disrupt the surgical anastomosis was 40.6 Ϯ 7.5 N (range, 31 to 50), which was greater than both the minimum and maximum fixation groups (P Ͻ .01).
DISCUSSION
Long-term success of endovascular aneurysm repair depends on secure intra-aortic device fixation. Failure of Most studies of migration have focused on proximal fixation to the infrarenal aortic neck. Efforts to prevent migration have been focused on improving proximal fixation mechanisms and identifying and avoiding treatment of patients with unfavorable neck anatomy. In vitro models have been used to evaluate and compare proximal fixation mechanisms of various stent-graft designs with measurement of resistance to downward displacement compared with sutured anastomoses. [16] [17] [18] [19] Resch et al 19 compared the proximal fixation of the Ancure (Guidant), Talent (Medtronic), Vanguard (Boston Scientific), Zenith (Cook), and the Palmaz (Cordis) stents with a hand-sewn surgical anastomosis. In this study, the proximal graft was placed in the aorta and attached by a hook to a dynamometer that was used to measure the displacement force. The distal end of the device was not deployed and was not fixed to iliac arteries. The median displacement force to cause endograft migration was 4.5 N for Talent, 9.0 N for Vanguard, 12.5 N for Ancure, 24 N for Zenith, and 25 N for Palmaz. The force needed to disrupt the sutured aortic anastomosis was 150 N. 19 Static experimental studies provide useful information on proximal fixation mechanisms, but they may not reflect in vivo behavior of devices because they do not take into account the dynamic in vivo environment. Furthermore, they do not take into account the intravascular position of the device, the iliac fixation component, or the longitudinal columnar characteristics of the device.
Morris et al 20 used a mathematical model to predict the in vivo pulsatile drag forces acting on a bifurcated stent graft used in the endovascular treatment of abdominal aortic aneurysms and defined the forces acting on the graft. These forces include the velocity of flow at the proximal and distal ends of the graft as well as the pressure and the velocity of flow through the body and limbs of the graft.
The reaction forces needed to counteract these drag forces included the proximal neck fixation length, the column strength of the main body of the graft, the column strength of the iliac limbs, and the fixation of the iliac limbs to the common iliac arteries. For a rigid graft with a proximal diameter of 24 mm and an iliac diameter of 12 mm, they calculated the variation in the drag force along the y-axis between 2.7 and 4.1 N during one cardiac cycle. 20 The authors determined that these were the minimum forces that stent grafts needed to withstand to provide adequate long-term fixation. Previous studies have only looked at the reactionary forces of proximal neck fixation length and various proximal neck stent configurations to prevent migration and have failed to consider iliac fixation length.
The importance of iliac fixation in improving the reaction forces to downward displacement has yet to be fully evaluated. However, from the results of this study, it appears there is a significant increase in the force needed to displace an aortic endograft that has longitudinal columnar strength when iliac fixation length is increased. We found that the force needed to displace the endograft was increased by 12 N (67%) when iliac fixation length was increased by 2 cm on each side.
Thus, it appears that the reactionary forces of iliac fixation length and, more important, the column strength of the iliac limbs are significant factors in resisting longitudinal loads that can cause stent-graft migration. This suggests that using longer endografts that extend to the hypogastric arteries or placing iliac extender modules to increase iliac fixation length in patients may reduce the likelihood of stent-graft migration. This has now become the standard in our clinical practice and is supported by retrospective review of our endograft experience. 21 Further prospective studies will be needed to confirm these observations. The pulsatile forces of aortic blood flow exert continuous downward displacement force on aortic devices, with cumulative effects over time. Thus, it is not surprising that migration has occurred and been reported with all current endovascular devices and configurations, including those with modular design, unibody design, infrarenal fixation, suprarenal fixation, hook and barb fixation, longitudinal columnar support, and flexible designs. The reported incidence of endograft migration varies widely and comparison is complicated by different definitions of migration and differing follow-up periods. Migration has been noted with all FDA-approved devices with similar migration rates of 2% at 1 year. [4] [5] [6] [7] Most studies have attributed this risk of migration to issues of the proximal neck. [8] [9] [10] [11] [12] [13] [14] [22] [23] Although in situ placement and maximum iliac fixation length of externally supported endografts significantly increases resistance to longitudinal device displacement, it still does not achieve the fixation security of hand-sewn surgical anastomoses as demonstrated in this and other studies. [16] [17] [18] [19] The AneuRx stent graft chosen in this study is held in place by radial force and columnar strength. Devices with other fixation mechanisms, including suprarenal stents, hooks and barbs, and differing columnar strength characteristics may behave differently and deserve to be studied. Such studies may help elucidate the relative importance of proximal and distal fixation and the role of columnar support in preventing device migration.
It should be recognized, however, that short-term experimental animal studies provide little insight to longterm device behavior. Late endograft failures have occurred in numerous devices after aortic implantation. Fatigue failures include delayed hook and barb fractures, metallic stent fractures, suture disruptions, and late failure of aortic neck attachments, [23] [24] [25] and these factors may have a role in late device migration.
The present study has several weaknesses. The first is that the endograft in the infrarenal aorta and iliac arteries was significantly oversized. This limitation was because of the size of the ovine aorta-iliac system and the size of have shown that device oversizing of Ͼ30% is associated with a higher risk of migration (14% migration rate) compared with those with Ͻ30% oversizing (0.9% migration rate). Furthermore, it has been shown that eccentric compression of the proximal graft of the AneuRx graft as a result of aggressive oversizing was associated with an increased risk of stent graft migration. 15 This suggests that the force needed to displace the endograft in this experiment might have been higher if the device could have been sized in accord with the recommended 10% to 20% oversizing. Nonetheless, there was no difference in the degree of oversizing between the two groups so the effect of incorrect oversizing should be the same in both groups.
The aortic neck length used in this experiment was 20 mm. This is similar to neck lengths commonly encountered in patients undergoing endovascular aneurysm repair. The mean aortic neck lengths of patients treated in prospective clinical trials of various endografts was Ն20 mm. [4] [5] [6] [7] However, migration most likely will occur in patients with aortic neck lengths Ͻ15 mm. Whether the in vivo forces necessary to displace the endograft downward would remain the same with maximum iliac fixation and a shorter proximal neck length would require further study.
Because this was a short-term study in which displacement forces were measured directly after implantation of the endograft, no conclusions can be drawn on the resistance to displacement of devices that have been in place for longer periods of time, and the study does not account for any possibility of biologic fixation of the graft that might occur. Further long-term studies should be performed to determine if length of implant results in a significant difference in displacement forces. Future studies should evaluate the long-term effect of iliac fixation and its role in migration in large clinical studies such as the multicenter AneuRx clinical trial.
In conclusion, increasing the iliac fixation length of a fully supported endovascular graft significantly increases the resistance to in vivo longitudinal stent-graft displacement in a short-term experimental model. This suggests that increasing iliac fixation length in patients may reduce the likelihood of stent-graft migration in patients. 
Dr Tim Chuter (San Francisco, Calif). Thank you, Doctor Arko, for sending me a copy of the paper to review. It is not easy to do meaningful animal studies of this type, and this study of column strength certainly deserves an "A" for effort. I agree with your conclusion that the addition of two extender limbs increased the pullout force at the proximal end of the stent graft. The question is, why and what does this mean in terms of clinical application?
The first thing to note is that the additional iliac stent grafts not only extended two centimeters down into the iliac arteries, but also three and a half centimeters up into the existing graft limbs within the distal aorta. In this ovine model, the distal aorta measured only thirteen millimeters in diameter and was barely big enough to accommodate one twelve-millimeter graft limb. With the addition of the iliac extensions it contained four. I suggest that the observed effects on pullout force showed the effects of additional bulk and stiffness. The top end of the stent-graft just had nowhere to go.
Can we expect to see the same effect in clinical use where the range of angulation is far larger, the aneurysm far wider, and one hundred percent oversizing is very unlikely? I think not. Angulation of the aorta is important because it increases the laterally directed component of any hemodynamic displacement forces and increases the likelihood of buckling.
The term column strength applies only to columns that are stiff and straight, not to stent grafts, which are flexible and bent. I agree with Doctor Arko that one should aim to implant a bifurcated stent graft of this type as close to the common iliac bifurcation as possible. This has been common practice among experienced users for a decade. But the best way to achieve adequate iliac overlap is not the routine addition of iliac extensions. Nor do I believe that iliac extensions increase the stability of the proximal end of the stent graft. Very long extensions might add a little stiffness to the limbs but not enough to have a significant effect on the incidence of proximal stent-graft migration, given the size and angulation of the typical infrarenal aortic aneurysm.
I have only one question for Doctor Arko. Where is the bifurcation of the common iliac artery in a sheep? Because as you know, the ovine internal iliac arteries are branches of the middle sacral artery. Thank you.
Dr Arko. There is a large branch that comes off the common iliac artery approximately three centimeters from the aortic bifurcation in a sheep. The graft was extended to that branch.
Dr James Watson (Seattle, Wash). I would like to congratulate Doctor Arko for what I consider to be a very elegant study. I don't understand how pulling on the distal end of the graft to test the proximal anastomosis can be affected by distal fixation. It seems like you are pulling on the distal fixation the same no matter how long that fixation is, so how can altering the length of distal fixation alter the strength at the proximal anastomosis?
Dr Arkro. Imagine the Eiffel Tower, it is very similar to that. It adds more column strength to the graft and, as Tim said, makes it stiffer. If you look at engineering models and computational fluid dynamics of endografts one can determine the amount of drag forces on an endograft. Those drag forces are based on the blood pressure and volume of flow at the proximal anastomosis, the distal anastomosis, and both distal fixation sites. However, there are multiple reactionary forces to counteract those drag forces and those include the proximal fixation length, the amount of oversizing, and the distal fixation of both the right and the left iliac limb as well as the column strength of the graft.
Dr William Quinones-Baldrich (Los Angeles, Calif). I want to congratulate you on the effort to create an animal model where we can study some of these things. It has been surprising to me that after ten years performing endovascular repair of abdominal aortic aneurysm, there are very few animal studies to evaluate the various designs. One of the main issues is whether it is the extension of the fixation site or the addition of columnar strength that is beneficial. Could you tell us if when the graft moved proximally, did it also move distally or did it just buckle? Dr Arko. That is a very good question. It buckled at the flow divider. We explanted these stent grafts and the iliac limbs were stiff throughout and the proximal portion of the graft was buckled.
Dr Ronald Dalman (Stanford, Calif). I would just like to make a comment, Frank. You know, I understand the point of a standardized pseudoaneurysm model, with measurable and reproducible diameter of the aneurysm, but what we are really talking about here is a normal aorta with a patch on it and not really an aneurysm. It is a pseudoaneurysm, so I think we have to move on to some more biologically relevant models, because this does provide a platform for comparing newton force but what causes the graft to migrate in traditional terms of an atherosclerotic aneurysm may be different than what causes it to move in a pseudoaneurysm with a patch on a normal aorta.
Dr Joseph Mills (Tucson, Ariz). I applaud you for trying to look at animal models because, as Doctor Quinones said, we don't have enough data for that, but what I am concerned about is does the animal model really apply to humans? Migration to me implies movement of the graft over time due to multiple issues, which could have to do with the proximal fixation length, distal fixation length, and also how much columnar support you have for the graft, and you are not really measuring migration. You are measuring the nonpulsatile force it takes to distract the proximal seal, which may not have anything to do with migration.
I am also concerned that with your model you are putting stiffer extensions inside your limbs and basically you are increasing your aortic seal because your aneurysms aren't that big. They are less than double the diameter of the native artery, so by putting these stiff supports in you are also increasing your fixation length in the distal aorta, not just the iliacs. I am not sure that you are measuring what you want to measure. Migration to me would mean you would measure movement over time so you would have to have a chronic model. Another way to get at it, which I think might be easier, is we all have serial MMS three-D CT measurements in all our patients. It would be easy to look at proximal fixation neck length, neck angulation, iliac fixation, and do a uni and multivariate analysis and see what factors actually influence migration. Dr Arko. I agree, and we have done that and that abstract has been submitted to the Southern Vascular.
Dr William Krupski (San Francisco, Calif). Frank, this isn't related to your model but have you noted in your clinical experience any proximal migration of grafts through the exoskeleton, kind of pushing it up if your graft is accordioned in the aorta? Have you seen that coverage of the renals after it has been put in? Dr Arko. Migrating cranially? Dr Krupski. Proximally, up toward the renals. Dr Arko. I have not seen that. I have heard about that in one case. I have also operated on a patient who had an endograft placed at an outside institution where the renals were supposedly visualized postprocedure and then a week later he became very hypertensive and one of his renals was completely covered and the other one was, I think about seventy percent covered. He was brought to us and I put a guide wire over the flow divider. I brought both ends of the guide wire out the femoral arteries and attempted to pull the graft down, but we just could not move the graft. It had been in there about four weeks, so I actually explanted that stent graft the following week and it was fairly well incorporated in both the iliacs and the proximal neck.
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